• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

展现出强大细胞毒性和选择性的新型铂(II)和铂(IV)抗肿瘤剂。

Novel Platinum(II) and Platinum(IV) Antitumor Agents that Exhibit Potent Cytotoxicity and Selectivity.

作者信息

Khoury Aleen, Elias Elias, Mehanna Stephanie, Shebaby Wassim, Deo Krishant M, Mansour Najwa, Khalil Christian, Sayyed Katia, Sakoff Jennette A, Gilbert Jayne, Daher Costantine F, Gordon Christopher P, Taleb Robin I, Aldrich-Wright Janice R

机构信息

School of Science, Western Sydney University, Locked Bag 1797, Penrith South, NSW 2751, Australia.

School of Natural Sciences, School of Arts and Sciences, Lebanese American University, P.O. Box 36, Byblos Lebanon.

出版信息

J Med Chem. 2022 Dec 22;65(24):16481-16493. doi: 10.1021/acs.jmedchem.2c01310. Epub 2022 Dec 8.

DOI:10.1021/acs.jmedchem.2c01310
PMID:36480933
Abstract

A novel platinum(II) complex and its platinum(IV) derivative were synthesized and characterized. Cytotoxicity studies against mesenchymal cells (MCs) and lung (A549), breast (MDA-MB-231), and melanoma (A375) cancer cells demonstrated 7-20-fold superior activity for both complexes relative to cisplatin. Remarkably, demonstrated 17-22-fold greater selectivity toward the cancerous cells compared to the non-cancerous MCs. Western blot analysis on A549 cells showed the involvement of the intrinsic apoptotic pathway. Cellular fractionation and uptake experiments in A549 cells using ICP-mass spectrometry (MS) indicated that and cross the cellular membrane predominantly via active transport mechanisms. The significant improvement in selectivity that is exhibited by is reported for the first time for this class of complexes.

摘要

合成并表征了一种新型铂(II)配合物及其铂(IV)衍生物。针对间充质细胞(MCs)以及肺癌(A549)、乳腺癌(MDA-MB-231)和黑色素瘤(A375)癌细胞的细胞毒性研究表明,这两种配合物的活性比顺铂高7至20倍。值得注意的是,与非癌细胞MCs相比,其对癌细胞的选择性高17至22倍。对A549细胞的蛋白质免疫印迹分析表明内源性凋亡途径参与其中。使用电感耦合等离子体质谱(ICP-MS)对A549细胞进行的细胞分级分离和摄取实验表明,该配合物主要通过主动转运机制穿过细胞膜。此类配合物首次报道了其在选择性方面的显著改善。

相似文献

1
Novel Platinum(II) and Platinum(IV) Antitumor Agents that Exhibit Potent Cytotoxicity and Selectivity.展现出强大细胞毒性和选择性的新型铂(II)和铂(IV)抗肿瘤剂。
J Med Chem. 2022 Dec 22;65(24):16481-16493. doi: 10.1021/acs.jmedchem.2c01310. Epub 2022 Dec 8.
2
Enhanced potency of a chloro-substituted polyaromatic platinum(II) complex and its platinum(IV) prodrug against lung cancer.氯取代多芳基铂(II)配合物及其铂(IV)前药增强对肺癌的效力。
Chem Biol Interact. 2024 Jan 25;388:110834. doi: 10.1016/j.cbi.2023.110834. Epub 2023 Dec 14.
3
In vitro and in vivo antitumor studies of potential anticancer agents of platinum(II) complexes of dicyclopentadiene and dithiocarbamates§.二环戊二烯与二硫代氨基甲酸盐的铂(II)配合物潜在抗癌剂的体外和体内抗肿瘤研究§
Metallomics. 2022 Aug 9;14(8). doi: 10.1093/mtomcs/mfac054.
4
Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations.半笼型金属铂(II)配合物作为抗癌剂:分子对接、细胞凋亡、细胞周期分析和细胞毒性活性评价。
Anticancer Agents Med Chem. 2022;22(6):1149-1158. doi: 10.2174/1871520621666210713112105.
5
A novel star-shaped trinuclear platinum(II) complex based on a 1,3,5-triazine core displaying potent antiproliferative activity against TNBC by the mitochondrial injury and DNA damage mechanism.一种基于 1,3,5-三嗪核心的新型星形三核铂(II)配合物,通过线粒体损伤和 DNA 损伤机制显示出对三阴性乳腺癌的强大抗增殖活性。
Dalton Trans. 2022 Jul 26;51(29):10930-10942. doi: 10.1039/d2dt00895e.
6
Chemotherapeutic Potential of Chlorambucil-Platinum(IV) Prodrugs against Cisplatin-Resistant Colorectal Cancer Cells.氯丁二醛-铂(IV)前药对顺铂耐药结直肠癌细胞的化疗潜力。
Int J Mol Sci. 2024 Jul 28;25(15):8252. doi: 10.3390/ijms25158252.
7
The Effects of Newly Synthesized Platinum(IV) Complexes on Cytotoxicity and Radiosensitization of Human Tumour Cells .新合成的铂(IV)配合物对人肿瘤细胞的细胞毒性和放射增敏作用
Anticancer Res. 2020 Sep;40(9):5001-5013. doi: 10.21873/anticanres.14503.
8
Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.新型含 5-甲基-5-(2-巯基乙基)乙内酰脲的铂配合物的合成、光谱性质、晶体结构和生物评价。
Anticancer Agents Med Chem. 2019;19(10):1243-1252. doi: 10.2174/1871520619666190214103345.
9
Dual-targeting antitumor conjugates derived from platinum(IV) prodrugs and microtubule inhibitor CA-4 significantly exhibited potent ability to overcome cisplatin resistance.铂(IV)前药和微管抑制剂 CA-4 衍生的双靶向抗肿瘤偶联物显著表现出克服顺铂耐药的强大能力。
Bioorg Chem. 2019 Nov;92:103236. doi: 10.1016/j.bioorg.2019.103236. Epub 2019 Aug 30.
10
Synthesis, characterization and biological activity of new cyclometallated platinum(iv) iodido complexes.新型环金属化铂(IV)碘化物配合物的合成、表征及生物活性。
Dalton Trans. 2017 Nov 7;46(43):14973-14987. doi: 10.1039/c7dt03448b.

引用本文的文献

1
Unveiling the chemotherapeutic potential of two platinum(IV) complexes in skin cancer: Insights.揭示两种铂(IV)配合物在皮肤癌中的化疗潜力:见解。
Curr Res Pharmacol Drug Discov. 2024 Oct 26;7:100205. doi: 10.1016/j.crphar.2024.100205. eCollection 2024.
2
Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity.轴向位置含有吲哚基衍生物 5-苯甲氧基吲哚-3-乙酸的铂(IV)前药表现出显著的抗癌活性。
Int J Mol Sci. 2024 Feb 11;25(4):2181. doi: 10.3390/ijms25042181.
3
Di-chlorido-(4,7-dimeth-oxy-1,10-phenanthroline-κ,')zinc(II).
二氯(4,7-二甲氧基-1,10-菲咯啉-κ)锌(II)
IUCrdata. 2024 Jan 12;9(Pt 1):x240037. doi: 10.1107/S2414314624000373. eCollection 2024 Jan.
4
Synthesis and Characterisation of Platinum(II) Diaminocyclohexane Complexes with Pyridine Derivatives as Anticancer Agents.铂(II)二胺环己烷配合物与吡啶衍生物的合成与表征作为抗癌剂。
Int J Mol Sci. 2023 Dec 5;24(24):17150. doi: 10.3390/ijms242417150.
5
The Antioxidant and Proapoptotic Effects of Bulb Ethanolic Extract on Triple-Negative and Estrogen-Dependent Breast Cancer Cells In Vitro.鳞茎乙醇提取物对三阴性和雌激素依赖性乳腺癌细胞的体外抗氧化及促凋亡作用
Plants (Basel). 2023 Jan 24;12(3):529. doi: 10.3390/plants12030529.
6
Potent Platinum(IV) Prodrugs That Incorporate a Biotin Moiety to Selectively Target Cancer Cells.含有生物素部分以选择性靶向癌细胞的强效铂(IV)前药。
Pharmaceutics. 2022 Dec 12;14(12):2780. doi: 10.3390/pharmaceutics14122780.